Calidi Biotherapeutics Inc. (NYSE American: CLDI) Focused on Advancing Stem Cell-Based Research Amid Rising Cancer Concerns
Rising cancer numbers indicate urgent need for advancements in cancer research, and stem cell research is rising to meet the challenge. Stem cells are being explored not only as a tool to regenerate damaged tissues but also as a delivery vehicle for innovative cancer treatments. Calidi Biotherapeutics stands at the forefront of integrating stem cell technology into oncology. As 2025 approaches, cancer continues to be one of the most significant global health challenges. Projections indicate a sharp increase in cancer diagnoses, with new cases in 2024 expected to surpass 2 million annually in the United States for the first time.…